Hib-DTP-hepatitis B vaccine - PT Bio Farma

Drug Profile

Hib-DTP-hepatitis B vaccine - PT Bio Farma

Alternative Names: Pentabio vaccine; Pentavalent vaccine - PT Bio Farma

Latest Information Update: 09 Jan 2015

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator PT Bio Farma
  • Class Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 30 Nov 2014 Hib meningitis vaccine technology licensed to PT Bio Farma (company pipeline)
  • 22 Aug 2013 Launched for Diphtheria, Haemophilus infections, Hepatitis B, Pertussis, Tetanus (In infants, In volunteers, Prevention) in Indonesia (IM)
  • 01 Dec 2010 Clinical trials in Diphtheria in Indonesia (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top